Hypershell builds AI-powered exoskeletons for mobility assistance across consumer, elderly care, and industrial use cases.
$50MSeries B+
Investor undisclosed
A $50M Series B+ for exoskeletons signals China's doubling down on robotics-as-infrastructure, especially for aging populations where labor costs are brutal. Hypershell is likely burning this on manufacturing scale and regulatory clearance across multiple geographies—exoskeletons need real-world validation data to move units. If you're building in adjacent hardware (prosthetics, wearable sensors, mobility software), watch how they solve the reimbursement problem; that's the actual moat, not the tech.